Affymetrix, Neomorphic Inc. deal

AFFX completed its previously announced acquisition of Neomorphic for 1.4 million AFFX shares, or $119 million based on AFFX’s Friday close at $84.922 (see BioCentury, Oct. 9). AFFX may choose to pay up to $20 million in cash in lieu of any increase in the number of shares to be paid under the buyout formula. ...